Literature DB >> 18514749

Signal transducer and activator of transcription 4 (STAT4), but not IL-12 contributes to Pseudomonas aeruginosa-induced lung inflammation in mice.

Rory O'Sullivan1, Svetlana O Carrigan, Jean S Marshall, Tong-Jun Lin.   

Abstract

Pseudomonas aeruginosa is a major opportunistic pathogen in immune-compromised individuals and cystic fibrosis patients. This organism stimulates a complex inflammatory response in the lung, including production of various cytokines and chemokines. The specific contribution of these mediators in the host defense against this bacterium has yet to be fully characterized. Interleukin-12 (IL-12) is commonly known as a master regulator of innate and adaptive immunity. IL-12 induces its biological effects through its associated intracellular signaling molecule, the signal transducer and activator of transcription 4 (STAT4). To examine a specific role of IL-12 and STAT4 in P. aeruginosa lung infection in mice, STAT4-deficient (STAT4-/-) and IL-12 p40-deficient (IL-12 p40-/-) mice were infected with P. aeruginosa intranasally. Interestingly, STAT4-/- mice, but not IL-12 p40-/- mice after 24h infection showed impaired production of the pro-inflammatory cytokines tumor necrosis factor, interleukin-1beta, and macrophage-inflammatory protein-2. However, neither STAT4 nor IL-12 p40 deficiency significantly affected INFgamma production or bacterial clearance compared to wild-type mice. Similarly, neutrophil recruitment was not affected in the STAT4-/- and IL-12 p40-/- mice. These results suggest that STAT4 contributes to P. aeruginosa-induced inflammation, but it is not essential for bacterial clearance. Although IL-12 is essential for the host defense against various pathogens, this cytokine is likely not a major player in the host response to P. aeruginosa lung infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18514749     DOI: 10.1016/j.imbio.2007.11.007

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

1.  Infection in systemic lupus erythematosus: friend or foe?

Authors:  Lisa Francis; Andras Perl
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

2.  Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis.

Authors:  Giovanni Di Bonaventura; Arianna Pompilio; Roberta Zappacosta; Francesca Petrucci; Ersilia Fiscarelli; Cosmo Rossi; Raffaele Piccolomini
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

Review 3.  Review: Toll-like receptors and NOD-like receptors in pulmonary antibacterial immunity.

Authors:  Theivanthiran Balamayooran; Gayathriy Balamayooran; Samithamby Jeyaseelan
Journal:  Innate Immun       Date:  2010-04-23       Impact factor: 2.680

Review 4.  Mechanisms of neutrophil accumulation in the lungs against bacteria.

Authors:  Gayathriy Balamayooran; Sanjay Batra; Michael B Fessler; Kyle I Happel; Samithamby Jeyaseelan
Journal:  Am J Respir Cell Mol Biol       Date:  2009-09-08       Impact factor: 6.914

5.  PTP1B negatively regulates nitric oxide-mediated Pseudomonas aeruginosa killing by neutrophils.

Authors:  Lei Yue; Min Yan; Michel L Tremblay; Tong-Jun Lin; Hua Li; Ting Yang; Xia Song; Tianhong Xie; Zhongping Xie
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

6.  CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection.

Authors:  Lei Yue; Zheng Pang; Hua Li; Ting Yang; Lei Guo; Longding Liu; Junjie Mei; Xia Song; Tianhong Xie; Ye Zhang; Xin He; Tong-Jun Lin; Zhongping Xie
Journal:  PLoS One       Date:  2018-10-08       Impact factor: 3.240

7.  STAT4 is expressed in neutrophils and promotes antimicrobial immunity.

Authors:  Pegah Mehrpouya-Bahrami; Alina K Moriarty; Paulo De Melo; W Coles Keeter; Nada S Alakhras; Andrew S Nelson; Madeline Hoover; Maria S Barrios; Jerry L Nadler; C Henrique Serezani; Mark H Kaplan; Elena V Galkina
Journal:  JCI Insight       Date:  2021-07-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.